|
|
Office Locations:
|
3835 Cleghorn Ave., Suite 300
Nashville, TN 37215
Phone: 615-843-9100
Fax: 615-313-9996
| | |
|
|
|
|
|
Food & Agriculture
Information Technology
Life Sciences & Healthcare
Medical Device
|
|
|
|
Mountain Group Partners (MGP) is an investor dedicated to investing in and actively guiding transformational businesses in the Life Sciences, AgTech and Technology sectors. Founded in 2002, MGP principals have invested in more than 50 companies in these sectors. MGP invests in seed and early stage companies. Within Life Sciences, the fund focuses on Medical Devices, Diagnostics, and Opportunistic Drug Development. Our firm places a premium on those innovations that have existing intellectual property or a novel scientific foundation for building intellectual property. AgTech investments focus on disruptive technologies that have a meaningful impact on global animal health and agriculture. Technology investments focus on Business and Healthcare Technology, targeting those ideas with quantifiable development risk and a rapid path to market.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
